Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02537522 · ClinicalTrials.gov registry record · Phase 4
Evaluation of 8.5 vs 9.0 Base Curve for 1-DAY ACUVUE(r) TruEye(r) Brand Contact Lenses
A Phase 4 study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- Phase 4
- Development phase
- 72
- Enrollment target
NCT02537522 is a Phase 4 study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 72 participants.
The verdict
NCT02537522, a Phase 4 study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 72 participants
- Enrollment target
Study Summary
The objective of this study is to determine if corneal diameter and keratometry readings correlate to subjective comfort and lens fitting characteristics.
Interventions
- DEVICE Contact Lenses with 8.5 BC
- DEVICE Contact Lenses with 9.0 BC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2015-07-01 |
| Est. Completion | 2015-07-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02537522
The ClinicalTrials.gov registry entry for NCT02537522 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Contact Lenses with 8.5 BC is the first listed.
NCT02537522 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02537522 about?
NCT02537522 is a clinical study titled "Evaluation of 8.5 vs 9.0 Base Curve for 1-DAY ACUVUE(r) TruEye(r) Brand Contact Lenses". The objective of this study is to determine if corneal diameter and keratometry readings correlate to subjective comfort and lens fitting characteristics.
What is the current status of trial NCT02537522?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 72 participants. The study started on 2015-07-01. Estimated completion is 2015-07-01.
What interventions are being tested in trial NCT02537522?
The interventions under investigation include: Contact Lenses with 8.5 BC (DEVICE), Contact Lenses with 9.0 BC (DEVICE).
Who is sponsoring clinical trial NCT02537522?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.